Hemlibra ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
288	自己免疫性後天性凝固因子欠乏症	3

288. 自己免疫性後天性凝固因子欠乏症

臨床試験数 : 206 / 薬物数 : 231 - (DrugBank : 28) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 21

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04567511 (ClinicalTrials.gov)	September 1, 2021	29/7/2020	Hemlibra in Mild Hemophilia A	Prospective, Single-Arm, Open-Label Use of Hemlibra(Emicizumab) in the Treatment of Mild Hemophilia ...	Factor VIII Deficiency, Congenital	Drug: Emicizumab	Indiana Hemophilia &Thrombosis Center, Inc.	Genentech, Inc.	Recruiting	5 Years	45 Years	Male	40	Phase 4	United States
2	EUCTR2019-004430-42-AT (EUCTR)	22/06/2021	22/04/2021	Evaluation of the effect of emicizumab in patients suffering from acute bleeds with previously no fa ...	Emicizumab in Patients with Acquired Hemophilia A: Multicenter, Single-Arm, Open-Label Clinical Tria ...	Acquired Hemophilia A (AHA) MedDRA version: 22.1;Level: LLT;Classification code 10053761;Term: Acqui ...	Trade Name: Hemlibra® INN or Proposed INN: Emicizumab Other descriptive name: RO5534262 EMICIZUMAB	GWT-TUD GmbH	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	47	Phase 2	Austria;Germany
3	EUCTR2019-004430-42-DE (EUCTR)	25/01/2021	20/11/2020	Evaluation of the effect of emicizumab in patients suffering from acute bleeds with previously no fa ...	Emicizumab in Patients with Acquired Hemophilia A: Multicenter, Single-Arm, Open-Label Clinical Tria ...	Acquired Hemophilia A (AHA) MedDRA version: 22.1;Level: LLT;Classification code 10053761;Term: Acqui ...	Trade Name: Hemlibra® INN or Proposed INN: Emicizumab Other descriptive name: RO5534262 EMICIZUMAB	GWT-TUD GmbH	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	47	Phase 2	Austria;Germany

First Previous1Next Last